{
    "clinical_study": {
        "@rank": "100826", 
        "acronym": "RIP", 
        "arm_group": {
            "arm_group_label": "Ranibizumab", 
            "arm_group_type": "Experimental"
        }, 
        "brief_summary": {
            "textblock": "The Ranibizumab in Pigment Epithelium Tears Secondary To Age-Related Macular Degeneration\n      (RIP) Study is a prospective, multicenter, uncontrolled, interventional phase 2 clinical\n      trial that investigates the effect of fixed monthly intravitreal injections of ranibizumab\n      (Lucentis, Novartis Pharma, Germany) on visual acuity and retinal morphology over a study\n      period of 12 months in 30 patients."
        }, 
        "brief_title": "Ranibizumab In Pigment Epithelium Tears Secondary To Age-Related Macular Degeneration Study", 
        "condition": "Age Related Macular Degeneration", 
        "condition_browse": {
            "mesh_term": "Macular Degeneration"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Diagnosis of a pigment epithelial tear secondary to age-related macular degeneration\n\n          -  Written informed consent\n\n        Exclusion Criteria:\n\n          -  Time of diagnosis more than 6 months before study recruitment\n\n          -  Ocular surgery of the study eye within 1 month before study recruitment\n\n          -  Extensive subretinal fibrosis or retinal atrophy of the study eye\n\n          -  Significant opacification of optical media of the study eye\n\n          -  Uncontrolled glaucoma of the study eye\n\n          -  Active ocular inflammation of the study eye\n\n          -  Best-corrected visual acuity of the contralateral eye below 20/200\n\n          -  Concurrent ocular or systemic therapy with other vascular endothelial growth factor\n             (VEGF)-inhibitory drugs"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "50 Years"
        }, 
        "enrollment": {
            "#text": "30", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "July 28, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01914159", 
            "org_study_id": "N-037.0156"
        }, 
        "intervention": {
            "arm_group_label": "Ranibizumab", 
            "description": "Monthly intravitreal injections", 
            "intervention_name": "Ranibizumab (Lucentis, Novartis Pharma GmbH, Germany)", 
            "intervention_type": "Drug"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "July 30, 2013", 
        "location": [
            {
                "contact": {
                    "email": "krohne@uni-bonn.de", 
                    "last_name": "Tim U Krohne, MD", 
                    "phone": "+49/228/287-15505"
                }, 
                "contact_backup": {
                    "email": "frank.holz@ukb.uni-bonn.de", 
                    "last_name": "Frank G Holz, MD", 
                    "phone": "+49/228/287-15505"
                }, 
                "facility": {
                    "address": {
                        "city": "Bonn", 
                        "country": "Germany", 
                        "zip": "53127"
                    }, 
                    "name": "University of Bonn, Department of Ophthalmology"
                }, 
                "investigator": [
                    {
                        "last_name": "Frank G Holz, MD", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Tim U Krohne, MD", 
                        "role": "Sub-Investigator"
                    }, 
                    {
                        "last_name": "Seleman Bedar, MD", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "armin.wolf@med.uni-muenchen.de", 
                    "last_name": "Armin Wolf, MD", 
                    "phone": "+49/89/5160-3811"
                }, 
                "facility": {
                    "address": {
                        "city": "M\u00fcnchen", 
                        "country": "Germany", 
                        "zip": "80336"
                    }, 
                    "name": "University of M\u00fcnchen (LMU), Department of Ophthalmology"
                }, 
                "investigator": [
                    {
                        "last_name": "Armin Wolf, MD", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Tine R Herold, MD", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "eter@uni-muenster.de", 
                    "last_name": "Nicole Eter, MD", 
                    "phone": "+49/251/83-56004"
                }, 
                "facility": {
                    "address": {
                        "city": "M\u00fcnster", 
                        "country": "Germany", 
                        "zip": "48149"
                    }, 
                    "name": "Universityof M\u00fcnster, Department of Ophthalmology"
                }, 
                "investigator": [
                    {
                        "last_name": "Nicole Eter, MD", 
                        "role": "Principal Investigator"
                    }, 
                    {
                        "last_name": "Christoph R Clemens, MD", 
                        "role": "Sub-Investigator"
                    }
                ], 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "Germany"
        }, 
        "number_of_arms": "1", 
        "overall_contact": {
            "email": "krohne@uni-bonn.de", 
            "last_name": "Tim U Krohne, MD", 
            "phone": "+49/228/287-15505"
        }, 
        "overall_contact_backup": {
            "email": "frank.holz@ukb.uni-bonn.de", 
            "last_name": "Frank G Holz, MD", 
            "phone": "+49/228/287-15505"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Germany: Paul-Ehrlich-Institut", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "February 2016", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Early Treatment of Diabetic Retinopathy Study (ETDRS) protocol", 
            "measure": "Best-corrected visual acuity", 
            "safety_issue": "No", 
            "time_frame": "12 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01914159"
        }, 
        "responsible_party": {
            "investigator_affiliation": "University Hospital, Bonn", 
            "investigator_full_name": "Frank G. Holz", 
            "investigator_title": "Director, Department of Ophthalmology, University of Bonn", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "Spectral-domain optical coherence tomography (SD-OCT), fundus autofluorescence imaging, fluorescence angiography", 
                "measure": "Retinal morphology", 
                "safety_issue": "No", 
                "time_frame": "12 months"
            }, 
            {
                "description": "Microperimetry", 
                "measure": "Visual field", 
                "safety_issue": "No", 
                "time_frame": "12 months"
            }, 
            {
                "description": "Visual function questionairy 25 (VFL-25)", 
                "measure": "Visual function quality of life", 
                "safety_issue": "No", 
                "time_frame": "12 months"
            }
        ], 
        "source": "University Hospital, Bonn", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University Hospital, Bonn", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "February 2013", 
        "study_design": "Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "July 2013"
    }
}